BioNote, Inc. (KRX:377740)

South Korea flag South Korea · Delayed Price · Currency is KRW
5,440.00
+70.00 (1.30%)
At close: Mar 13, 2026
Market Cap551.41B +17.6%
Revenue (ttm)115.09B +15.3%
Net Income117.65B +191.5%
EPS1,160.97 +193.9%
Shares Out101.36M
PE Ratio4.69
Forward PEn/a
Dividend200.00 (3.68%)
Ex-Dividend DateMar 30, 2026
Volume142,138
Average Volume175,707
Open5,400.00
Previous Close5,370.00
Day's Range5,280.00 - 5,500.00
52-Week Range4,150.00 - 6,320.00
Beta0.89
RSI46.08
Earnings DateFeb 25, 2026

About BioNote

BioNote, Inc., manufactures and sells in-vitro diagnostic animal medicines in South Korea. It offers animal diagnostics products, such as fluorescence immunoassay, molecular diagnostics, clinical biochemistry, rapid immunoassay, and enzyme-linked immunosorbent assay products. The company also provides bio-content products, including rapid immunoassay for humans, human intermediate goods, and bio-contents reagents. In addition, it engages in the production and sell of medical devices. BioNote, Inc. was founded in 2003 and is headquartered in Hwa... [Read more]

Sector Healthcare
Founded 2003
Employees 298
Stock Exchange Korea Stock Exchange
Ticker Symbol 377740
Full Company Profile

Financial Performance

Financial Statements